UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient

Cancer biology & therapy, 2023-12, Vol.24 (1), p.2193116-2193116

2023

Link zum Volltext

Verfügbarkeit prüfen

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study

Swiss medical weekly, 2021-03, Vol.151, p.w20464

2021

Link zum Volltext

Verfügbarkeit prüfen

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)

BMC cancer, 2021-02, Vol.21 (1), p.182-182, Article 182

2021

Link zum Volltext

Verfügbarkeit prüfen

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.881-889

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study

Cancers, 2022-07, Vol.14 (14), p.3522

2022

Link zum Volltext

Verfügbarkeit prüfen

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)

Journal of bone oncology, 2020-04, Vol.21, p.100273-100273, Article 100273

2020

Link zum Volltext

Verfügbarkeit prüfen

The case of an extensive primary extramammary Paget's disease diagnosis and treatment

International Journal of Case Reports and Images (IJCRI), 2017-01, Vol.8 (1), p.46

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer as a chronic disease: what changes for our practice?

Revue médicale suisse, 2016-01, Vol.12 (503), p.167

Anchisi, Sandro

2016

Link zum Volltext

Verfügbarkeit prüfen

Rising to the medication's requirements: The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics field

Social science & medicine, 2019-12, Vol.242, p.112593-112593, Article 112593

2019

Link zum Volltext

Verfügbarkeit prüfen

Pain and cancer: what are our means?

Revue médicale suisse, 2014-01, Vol.10 (415), p.288

Anchisi, Sandro

2014

Link zum Volltext

Verfügbarkeit prüfen

Advanced lung cancer: supportive care

Revue médicale suisse, 2013-01, Vol.9 (371), p.269

Anchisi, Sandro

2013

Link zum Volltext

Verfügbarkeit prüfen

PARP inhibitors - A better selection of patients

Revue médicale suisse, 2023-05, Vol.19 (827), p.932

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of RAS status and prior targeted therapy on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in daily practice. Final results of the QoLiTrap prospective non-interventional study

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e15570-e15570

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross‐sectional survey

European journal of cancer care, 2022-11, Vol.31 (6), p.e13705-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy with immune checkpoint inhibitors and hepatitis

Revue médicale suisse, 2019-05, Vol.15 (651), p.1017

2019

Link zum Volltext

Verfügbarkeit prüfen

Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data

Oncology, 2018-01, Vol.95 (2), p.61-68

2018

Link zum Volltext

Verfügbarkeit prüfen

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study

Journal of geriatric oncology, 2023-11, Vol.14 (8), p.101638-101638, Article 101638

2023

Link zum Volltext

Verfügbarkeit prüfen

Pemetrexed-associated radiation recall dermatitis

Acta oncologica, 2008, Vol.47 (8), p.1607-1608

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of Treatments on the Family of Breast, Prostate, Colon and Lung Cancer Patients

Cancer and clinical oncology, 2017-04, Vol.6 (1), p.61

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

Supportive care in cancer, 2013-09, Vol.21 (9), p.2565-2573

2013

Link zum Volltext

Verfügbarkeit prüfen

Going through chemotherapy: an age-revealing process

Bulletin du cancer, 2008-05, Vol.95 FMC Onco, p.F44

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(34)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(23)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Oncology
(15)
Male
(14)
Aged
(12)
Female
(12)
Middle Aged
(10)
Adult
(6)
Aged, 80 And Over
(6)
Quality Of Life
(6)
Cancer
(5)
Cancer Therapies
(5)
Patients
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Colorectal Cancer
(4)
Combined Modality Therapy
(4)
Lung Neoplasms - Pathology
(4)
Metastasis
(4)
Neoplasms - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient

Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study

Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16)

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study

Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16)

The case of an extensive primary extramammary Paget's disease diagnosis and treatment

Cancer as a chronic disease: what changes for our practice?

Rising to the medication's requirements: The experience of elderly cancer patients receiving palliative chemotherapy in the elective oncogeriatrics field

Pain and cancer: what are our means?

Advanced lung cancer: supportive care

PARP inhibitors - A better selection of patients

Impact of RAS status and prior targeted therapy on the activity of aflibercept plus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in daily practice. Final results of the QoLiTrap prospective non-interventional study

Patients' experiences with cancer care in Switzerland: Results of a multicentre cross‐sectional survey

Immunotherapy with immune checkpoint inhibitors and hepatitis

Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data

Quality of life, effectiveness, and safety of aflibercept plus FOLFIRI in older patients with metastatic colorectal cancer: An analysis of the prospective QoLiTrap study

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial

Pemetrexed-associated radiation recall dermatitis

Impact of Treatments on the Family of Breast, Prostate, Colon and Lung Cancer Patients

Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment

Going through chemotherapy: an age-revealing process

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel versus bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer—A multicenter, randomized phase III trial

Suchergebnisse filtern